Abstract: The present technology generally relates to compositions comprising cannabinoids for relieving pain in a subject and to methods of using such compositions for relieving pain in a subject.
Type:
Grant
Filed:
August 5, 2021
Date of Patent:
November 8, 2022
Assignee:
TWEED INC.
Inventors:
Mark Andrew Hetherington, Chris Schnarr
Abstract: The present technology generally relates to compositions comprising cannabinoids for relieving pain in a subject and to methods of using such compositions for relieving pain in a subject.
Type:
Grant
Filed:
November 1, 2019
Date of Patent:
September 7, 2021
Assignee:
TWEED INC.
Inventors:
Mark Andrew Hetherington, Chris Schnarr
Abstract: The invention relates to novel genetically modified plants and methods or materials, such as polynucleotides, expression cassettes, or vectors for producing the same. Moreover, the invention relates to altering the content of cannabinoids in plants and to medical compositions derived from such plants. In particular embodiments, the present invention relates to cannabis plants having modified expression of tetrahydrocannabinolic acid (THCA) synthase and methods of modifying the amount of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in cannabis by modifying expression of THCA synthase.
Type:
Grant
Filed:
May 27, 2016
Date of Patent:
March 2, 2021
Assignee:
Tweed, Inc.
Inventors:
Ekaterina Alexandra Boudko, Thomas IV Shipley, Douglas Johnson